drugset / Trial / NCT02847013
The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section
RandomizedParallel-groupTriple-blindTreatment
Summary
This present investigation aims to determine whether a transversus abdominous plane(TAP) block, utilizing liposomal bupivacaine (Exparel), at the conclusion of a cesarean section decreases post-operative pain. The hypothesis is that performance of the TAP block with liposomal bupivacaine will decrease post-operative narcotic use.
Timeline
- Start
- —
- Primary completion
- 2019-12-17
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.66 % | Other |
Indications
No indication recorded.